Log in to save to my catalogue

FGFR1 and NTRK3 actionable alterations in “Wild-Type” gastrointestinal stromal tumors

FGFR1 and NTRK3 actionable alterations in “Wild-Type” gastrointestinal stromal tumors

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5157084

FGFR1 and NTRK3 actionable alterations in “Wild-Type” gastrointestinal stromal tumors

About this item

Full title

FGFR1 and NTRK3 actionable alterations in “Wild-Type” gastrointestinal stromal tumors

Publisher

England: BioMed Central Ltd

Journal title

Journal of translational medicine, 2016-12, Vol.14 (1), p.339-339, Article 339

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

About 10-15% of adult, and most pediatric, gastrointestinal stromal tumors (GIST) lack mutations in KIT, PDGFRA, SDHx, or RAS pathway components (KRAS, BRAF, NF1). The identification of additional mutated genes in this rare subset of tumors can have important clinical benefit to identify altered biological pathways and select targeted therapies.

Alternative Titles

Full title

FGFR1 and NTRK3 actionable alterations in “Wild-Type” gastrointestinal stromal tumors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5157084

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5157084

Other Identifiers

ISSN

1479-5876

E-ISSN

1479-5876

DOI

10.1186/s12967-016-1075-6

How to access this item